COMMITMENTS AND CONTINGENCIES (Details) $ in Thousands			3 Months Ended	12 Months Ended
	Jun. 19, 2023 Batch	Apr. 01, 2019 USD ($)	Jun. 30, 2023 USD ($)	Dec. 31, 2023 USD ($) Term Tranche Facility	Dec. 31, 2022 USD ($)	Dec. 31, 2021 USD ($)	Jun. 15, 2022 USD ($)	Sep. 30, 2021 USD ($)
Vendor and Licensor Commitments [Abstract]
Number of batches in production at the time of disruption | Batch	2
Non recurring charge of inventory			$ 2,100
Impact of operating expenses			$ 700	$ 4,266	$ 17,843	$ 12,289
Plasma supply agreement term				10 years
Post-Marketing Commitments [Abstract]
Amount of expenses to complete studies		$ 1,500		$ 3,300	3,614	3,646
Other Commitments [Abstract]
Number of tranches | Tranche				2
BIVIGAM [Member]
Post-Marketing Commitments [Abstract]
Amount of expenses to complete studies				$ 1,700	2,200	1,700
ASCENIV [Member]
Post-Marketing Commitments [Abstract]
Amount of expenses to complete studies				$ 1,000	500	$ 600
Maximum [Member]
Vendor and Licensor Commitments [Abstract]
IT technology systems inaccessible period	7 days
Employee Retention Program [Member]
Other Commitments [Abstract]
Retention amount paid to employees, tranche one								$ 1,300
Amount of first tranche recognized over the retention service period					$ 800
Employee Retention Program [Member] | Plan [Member]
Other Commitments [Abstract]
Retention amount payable to employees, second tranche							$ 1,300
2011 Plasma Purchase Agreement [Member]
Vendor and Licensor Commitments [Abstract]
Number of renewal terms | Term				2
Plasma purchase agreement renewal period				5 years
2011 Plasma Purchase Agreement [Member] | Maximum [Member]
Vendor and Licensor Commitments [Abstract]
Number of plasma collection facilities | Facility				5